- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01855126
Individually Tailored Lighting System to Improve Sleep in Older Adults
January 7, 2019 updated by: Mariana G Figueiro, Rensselaer Polytechnic Institute
In conjunction with investigators at the Cecil G. Sheps Center for Health Services Research, University of North Carolina (UNC) at Chapel Hill, we propose to develop and evaluate a low-cost, minimally obtrusive device that delivers individualized light therapy to adults with early-awakening insomnia - the most common sleep disturbance in older adults, and a significant problem because of its relationship to daytime sleepiness, use of potentially hazardous sleep medication, and reduced quality of life.
The proposed device will measure light/dark exposure data over 24 hours, estimate optimum timing for light delivery, and deliver an individualized light dosage while subjects are asleep.
Light applied through closed eyelids in the early part of the night will delay the dim light melatonin onset, a marker of the circadian clock, and help those with early sleep onset to fall asleep later
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
We will recruit 50 subjects who report going to bed early and desiring later bedtimes and will ask them to wear an active and an inactive light mask for 8 consecutive weeks each.
A 2-week washout period between active and inactive conditions will be applied.
Outcome measures will be collected periodically throughout the 8 weeks.
Baseline (no intervention) will be collected prior to the active and inactive lighting interventions.
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Troy, New York, United States, 12180
- Rensselaer Polytechnic Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 65 or older
- cognitively capable
- able to respond to study staff verbally and in English
- score greater than 6 using the Pittsburgh Sleepiness Quality Index
- suffer from insomnia
- suffer from excessive daytime sleepiness
Exclusion Criteria:
- Severe sleep apnea
- Severe restless leg syndrome (RLS)
- Significant cognitive impairment
- History of severe photosensitivity dermatitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Blue light
The study protocol consisted of two 8-week intervention/control periods in which each participant wore either the intervention (blue light) or control (red light) mask every night, with the order of presentation of the two conditions randomized by the study's biostatistician.
A light mask housing two blue Light Emitting Diodes (LED) arrays delivered a train of blue or red light pulses of 2 second duration that were presented every 30 s for no longer than 2 hr, resulting in a maximum total of approximately 240 pulses per night.
the blue light mask was worn nightly for 8 weeks.
There will be a two week washout period between each intervention
|
After a two week baseline collection period, half of the subjects will initially be given light masks that deliver blue light through the closed eyelids, while subjects are sleeping.
The light mask will always be turned on 120 min before estimated core body temperature minimum (CBTmin); it is expected that blue light exposure will delay the timing of the CBTmin.
|
|
Placebo Comparator: Red light
The study protocol consisted of two 8-week intervention/control periods in which each participant wore either the intervention (blue light) or control (red light) mask every night, with the order of presentation of the two conditions randomized by the study's biostatistician.
A light mask housing two red Light Emitting Diodes (LED) arrays delivered a train of blue or red light pulses of 2 second duration that were presented every 30 s for no longer than 2 hr, resulting in a maximum total of approximately 240 pulses per night.
the red light mask was worn nightly for 8 weeks, with a two week washout period between each intervention
|
After a two week baseline collection period, half of the subjects will initially be given light masks that deliver red light through the closed eyelids, while subjects are sleeping.
The light mask will always be turned on 120 min before estimated core body temperature minimum (CBTmin); it is expected that red light exposure will have no effect on the timing of the CBTmin.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Disturbance
Time Frame: Baseline (week 0) and week 8 of lighting intervention
|
Pittsburgh Sleep Quality Index. Score range 0 - 21. A score over 5 is indicative of sleep disturbance. Change in score from baseline to intervention is reported. A larger difference indicates a better outcome. |
Baseline (week 0) and week 8 of lighting intervention
|
|
Total Sleep Time
Time Frame: baseline week (week 0) and the last week of intervention (week 8)
|
The change in total amount of minutes spent sleeping at night from baseline week to the last week of intervention.
A higher number is an improved outcome
|
baseline week (week 0) and the last week of intervention (week 8)
|
|
Sleep Efficiency
Time Frame: baseline week (week 0) and the last week of intervention (week 8)
|
The change in sleep efficiency from baseline to last week of intervention.
A higher number is a better outcome.
Sleep efficiency is the percentage of time spent in bed sleeping.
Scored total sleep time divided by interval duration minus total invalid time (sleep/wake) of the given rest interval multiplied by 100.
This data was collected using actigraphy data.
|
baseline week (week 0) and the last week of intervention (week 8)
|
|
Sleep Start Time
Time Frame: baseline week (week 0) and the last week of intervention (week 8)
|
Change in sleep start time, in minutes, from baseline week to the last week of intervention.
A higher number is a better outcome.
Based on actigraph data
|
baseline week (week 0) and the last week of intervention (week 8)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mariana G Figueiro, PhD, Rensselaer Polytechnic Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Figueiro MG, Plitnick B, Rea MS. Pulsing blue light through closed eyelids: effects on acute melatonin suppression and phase shifting of dim light melatonin onset. Nat Sci Sleep. 2014 Dec 2;6:149-56. doi: 10.2147/NSS.S73856. eCollection 2014.
- Figueiro MG, Bierman A, Rea MS. A train of blue light pulses delivered through closed eyelids suppresses melatonin and phase shifts the human circadian system. Nat Sci Sleep. 2013 Oct 4;5:133-41. doi: 10.2147/NSS.S52203. eCollection 2013.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
May 9, 2013
First Submitted That Met QC Criteria
May 15, 2013
First Posted (Estimate)
May 16, 2013
Study Record Updates
Last Update Posted (Actual)
January 29, 2019
Last Update Submitted That Met QC Criteria
January 7, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01AG042602 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disturbances
-
Kafrelsheikh UniversityNot yet recruiting
-
Saipriya GowrishankarMaharishi International UniversityActive, not recruitingSleep Disturbances in PerimenopauseUnited States
-
Chinese University of Hong KongRecruitingSleep | Sleep Disturbances | Sleep Disturbances in ChildrenHong Kong
-
St. Joseph's Healthcare HamiltonMcMaster UniversityNot yet recruiting
-
Assiut UniversityNot yet recruitingDepressive Disorder | Sleep Disturbances
-
University of MalagaNot yet recruitingStress | Insomnia | Sleep Disturbances
-
Chi Mei Medical HospitalEnrolling by invitationSleep Disturbances and InsomniaTaiwan
-
Rutgers, The State University of New JerseyRecruitingSleep Disturbances | Cancer SurvivorshipUnited States
-
Taipei Medical University Shuang Ho HospitalRecruitingDepression | Sleep DisturbancesTaiwan
-
Konya City Hospitalnecmettin erbakan university Scientific Research Projects (BAP)CompletedPostoperative Sleep DisturbancesTurkey
Clinical Trials on Blue light
-
Beijing Tongren HospitalCompletedLongitudinal Chromatic Aberration | Blue Light Defocus ManipulationChina
-
University of PittsburghNational Institute of Mental Health (NIMH)RecruitingDepression in Adolescence | Depression in AdultsUnited States
-
University of FloridaNational Institute of Dental and Craniofacial Research (NIDCR)Recruiting
-
Shanghai Zhongshan HospitalFudan University; Shanghai Mental Health Center, Jingan District; Shanghai Mental...Unknown
-
University of PittsburghWithdrawn
-
Glostrup University Hospital, CopenhagenPhilips Healthcare; Elforsk; Albertslund Kommune; Gate 21; DTU Fotonik; VISO systems; AF Lightning and other collaboratorsCompleted
-
Chang Gung Memorial HospitalRecruitingDelirium | Circadian DysrhythmiaTaiwan
-
Matthew Neal MDTerminatedPancreatic Neoplasms | Rectal NeoplasmsUnited States
-
Philips RespironicsCompletedSeasonal Affective DisorderUnited States
-
Portsmouth Hospitals NHS TrustKing's College Hospital NHS Trust; Göteborg University; Catharina Ziekenhuis... and other collaboratorsCompleted